New hope for Tough-to-Treat blood cancer: experimental drug enters Mid-Stage trial

NCT ID NCT07266441

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental drug called JNJ-79635322 for people with multiple myeloma, a blood cancer, that has come back or stopped responding to at least three prior standard treatments. The main goal is to see how well the drug works to control the cancer and measure its safety. Researchers will also track how the treatment affects participants' symptoms and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cancer Care Specialists of Central Illinois
RECRUITING

O'Fallon, Illinois, 62269, United States
Cancer Specialists of North Florida
RECRUITING

Jacksonville, Florida, 32256, United States
Cancer and Blood Specialty Clinic
RECRUITING

Los Alamitos, California, 90720, United States
City of Hope
RECRUITING

Duarte, California, 91010, United States
City of Hope Orange County Lennar Foundation Cancer Center
RECRUITING

Irvine, California, 92618, United States
Cleveland Clinic Foundtation
RECRUITING

Cleveland, Ohio, 44195, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Ha'Emek Medical Center
RECRUITING

Afula, 1834111, Israel
Hadassah Medical Center
RECRUITING

Jerusalem, 9112000, Israel
Hillel Yaffe Medical Center
RECRUITING

Hadera, 3820302, Israel
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
Mission Cancer Blood
RECRUITING

Waukee, Iowa, 50263, United States
National Hospital Organization Okayama Medical Center
RECRUITING

Okayama, 701-1192, Japan
National Hospital Organization Shibukawa Medical Center
RECRUITING

Gunma, 377-0280, Japan
NorthWest Medical Specialties, PLLC
RECRUITING

Tacoma, Washington, 98405, United States
Northside Hospital Cancer Institute
RECRUITING

Atlanta, Georgia, 30342, United States
Oncology Consultants Texas
RECRUITING

Houston, Texas, 77030, United States
Rabin Medical Center
RECRUITING

Petah Tikva, 4941492, Israel
Rutgers Cancer Institute
RECRUITING

New Brunswick, New Jersey, 08901, United States
Samson Assuta Ashdod University Hospital
RECRUITING

Ashdod, 7747629, Israel
Tel Aviv Sourasky Medical Center
RECRUITING

Tel Aviv, 6423906, Israel
University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA